CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

AKUMS DRUGS & PHARMACEUTICALS LTD.

NSE : AKUMSBSE : 544222ISIN CODE : INE09XN01023Industry : Pharmaceuticals & DrugsHouse : Private
BSE668.1060.7 (+9.99 %)
PREV CLOSE () 607.40
OPEN PRICE () 619.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 133956
TODAY'S LOW / HIGH ()608.05 668.10
52 WK LOW / HIGH ()527 1174.85
NSE668.4060.75 (+10 %)
PREV CLOSE() 607.65
OPEN PRICE () 612.70
BID PRICE (QTY) 668.40 (77173)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2105937
TODAY'S LOW / HIGH() 608.05 668.40
52 WK LOW / HIGH ()530.05 1175.9
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2004

Management Info :

- Chairman Sanjeev Jain - Managing Director

Registered Office :

Address : 304 Mohan Place, L S C ,Saraswati Vihar, ,
Delhi,
Delhi-110034

Phone : 011- 69041000

Email : cs@akums.net

Website : www.akums.in

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
24Dec Akums Drugs enters into agreement for
Akums Drugs & Pharmaceuticals has entered into an agreement with one..
26Nov Akums Drugs’ arm collaborates with Jag
Akums Drugs & Pharmaceuticals’ wholly owned subsidiary -- Maxcure Nu..
26Nov Akums Drugs and Pharmaceuticals inform
Akums Drugs and Pharmaceuticals has informed that Maxcure Nutravedics (M..
21Nov Akums Drugs touches roof on the BSE
Akums Drugs is locked its upper circuit limit at Rs. 609.95, up by 29.00..
19Nov Akums Drugs enters into exclusive Mast
Akums Drugs and Pharmaceuticals has entered into an exclusive Master Sal..
Financials
in Millions
QTR Sep 24 ANNUAL
Net Profit503.66
Gross Profit 616.2
Operating Profit 751.9
Net Sales
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 29300.05 (2.33%)
M.Cap ( in Cr)
62260.56
Neuland Laboratories (BSE)
 13712.60 (1.98%)
M.Cap ( in Cr)
17593.11
Ajanta Pharma (BSE)
 3039.45 (8.73%)
M.Cap ( in Cr)
37966.41
Caplin Point Lab (BSE)
 2596.45 (8.32%)
M.Cap ( in Cr)
19736.06
Alkem Laboratories (BSE)
 5481.75 (1.43%)
M.Cap ( in Cr)
65542.54
Shareholding Pattern
PROMOTERS 75.26%
NON-INSTITUTION 10.16%
MUTUAL FUNDS/UTI 5.18%
FI/BANKS/INSURANCE 1.72%
GOVERNMENT 0%
FII 0%
Mf Holding
Scheme NameHold(%)
No Data Found

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX78699.07226.59 (0.29%)
NIFTY23813.4063.20 (0.27%)
Dow Jones 43325.8028.77 (0.07%)
Nasdaq 20020.36-10.77 (-0.05%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI